← Open Payments lookup

EMILEA HARSHMAN: Open Payments

NPI 1831684216 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,007 in 56 payments from 21 companies in 2025. Trend: 2023 $759 · 2024 $1,246 · 2025 $1,007

Food & beverage: $1,007
CompanyPaymentsAmount
PFIZER INC.12$205
Lilly USA, LLC10$132
Novo Nordisk Inc5$88
ABBVIE INC.3$83
Astellas Pharma US Inc2$68
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$65
AstraZeneca Pharmaceuticals LP2$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$36
Axsome Therapeutics, Inc.2$33
Kowa Pharmaceuticals America, Inc.2$30

Products named: NURTEC ODT, VRAYLAR, Veozah, CAPLYTA, MOUNJARO, PREVNAR 20, REXULTI, KISUNLA.

Industry payments across NE — which companies pay providers there.